PACB - PacBio prices upsized $150M public offering
- PacBio ( NASDAQ: PACB ) has priced an upsized public offering of common stock expected to bring in $175M at $10 per share.
- The offering is for 17.5M shares. Underwriters have a 30-day option to purchase and additional 2.625M shares.
- The offering was originally for $150M worth of shares .
- Read why Seeking Alpha contributor Nelson Alves says that PacBio ( PACB ) is a buy.
For further details see:
PacBio prices upsized $150M public offering